Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance

International Journal of Neuropsychopharmacology

Volumn 17, Issue 5, 2014, Pages 765-777

  Benmansour, Saloua ^a   Privratsky, Anthony A ^a   Adeniji, Opeyemi S ^a   Frazer, Alan ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

ER agonist; estradiol; serotonin transporter; signaling pathways; SSRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUVOXAMINE; G PROTEIN COUPLED RECEPTOR 30; METABOTROPIC RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN C RECEPTOR; 1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; 2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE; ESTROGEN; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; NITRILE; PYRAZOLE DERIVATIVE; SEROTONIN ANTAGONIST; SLC6A4 PROTEIN, RAT;

AMPEROMETRY; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN REGION; CHRONOAMPEROMETRY; CLEARANCE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPAL CA3 REGION; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; DRUG EFFECTS; FEMALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CA3 REGION, HIPPOCAMPAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FLUVOXAMINE; MAP KINASE SIGNALING SYSTEM; NITRILES; OVARIECTOMY; PROTO-ONCOGENE PROTEINS C-AKT; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, IGF TYPE 1; RECEPTOR, TRKB; RECEPTORS, METABOTROPIC GLUTAMATE; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84897444582     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571300165X     Document Type: Article

References (78)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995) PD 098059 is a specific inhibitor of the activation of mitogen-Activated protein kinase kinase in vitro and in viva. J Biol Chem 270:27489-27494
2. Alonso A, Gonzalez C (2012) Neuroprotective role of estrogens: Relationship with insulin/IGF-1 signaling. Front Biosci (Elite Ed) 1:607-619
3. Arevalo MA, Ruiz-Palmero I, Scerbo MJ, Acaz-Fonseca E, Cambiasso MJ, Garcia-Segura LM (2012) Molecular mechanisms involved in the regulation of neuritogenesis by estradiol: Recent advances. J Steroid Biochem Mol Biol 131:52-56
4. Artigas F (2013) Developments in the field of antidepressants, where do we go now? Eur Neuropsychopharmacol. S0924-977X(13)00144-2. doi: 10.1016/j.euroneuro.2013.04.013 [Epub ahead of print].
5. Benmansour S, Deltheil T, Piotrowski JP, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ (2008) Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol 587:90-98
6. Benmansour S, Piotrowski JP, Altamirano AV, Frazer A (2009) Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacol 34:555-564
7. Benmansour S, Weaver RS, Barton AK, Adeniji OS, Frazer A (2012) Comparison of the effects of estradiol and progesterone on serotonergic function. Biol Psychiatry 71:633-641
8. Blakely RD, Defelice LJ, Galli A (2005) Biogenic amine neurotransmitter transporters: Just when you thought you knew them. Physiology (Bethesda) 20:225-231
9. Boulware MI, Weick JP, Becklund BR, Kuo SP, Groth RD, Mermelstein PG (2005) Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci 25:5066-5078
10. Boulware MI, Kordasiewicz H, Mermelstein PG (2007) Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J Neurosci 27:9941-9950
11. Bourque M, Dluzen DE, Di Paolo T (2012) Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease. Front Neuroendocrinol 33:169-178
12. Brinton RD (2008) Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's disease. Adv Drug Deliv Rev 60:1504-1511
13. Cardona-Gómez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM (2002) Interactions of estrogen and insulinlike growth factor-I in the brain: Molecular mechanisms and functional implications. J Steroid Biochem Mol Biol 83:211-217
14. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM (2008) Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacol 55:1006-1014
15. Dewing P, Boulware MI, Sinchak K, Christensen A, Mermelstein PG, Micevych P (2007) Membrane estrogen receptor-Alpha interactions with metabotropic glutamate receptor 1a modulate female sexual receptivity in rats. J Neurosci 27:9294-9300
16. Dominguez R, Jalali C, De Lacalle S (2004) Morphological effects of estrogen on cholinergic neurons in vitro involves activation of extracellular signal-regulated kinases. J Neurosci 24:982-990
17. Dominguez R, Liu R, Baudry M (2007) 17-Beta-estradiol-mediated activation of extracellular-signal regulated kinase, phosphatidylinositol 3-kinase/protein kinase B-Akt and N-methyl-D-Aspartate receptor phosphorylation in cortical synaptoneurosomes. J Neurochem 101:232-240
18. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS (2007) A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 61:661-670
19. Duric V, Duman RS (2013) Depression and treatment response: Dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci 70:39-53
20. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77:916-928
21. Eaton SA, Jane DE, Jones PL, Porter RH, Pook PC, Sunter DC, Udvarhelyi PM, Roberts PJ, Salt TE, Watkins JC (1993) Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-Alpha-methyl-4-carboxyphenylglycine. Eur J Pharmacol 244:195-197
22. Etgen AM, Ansonoff MA, Quesada A (2001) Mechanisms of ovarian steroid regulation of norepinephrine receptor-mediated signal transduction in the hypothalamus: Implications for female reproductive physiology. Horm Behav 40:169-177
23. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a novel inhibitor of mitogen-Activated protein kinase. J Biol Chem 273:18623-18632
24. Fortress AM, Fan L, Orr PT, Zhao Z, Frick KM (2013) Estradiol-induced object recognition memory consolidation is dependent on activation of mTOR signaling in the dorsal hippocampus. Learn Mem 20:147-155
25. Furmaga H, Carreno FR, Frazer A (2012) Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS ONE 7:e34844. doi:10.1371/journal. pone.0034844
26. Garcia-Segura LM, Arévalo MA, Azcoitia I (2010) Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: New advances. Prog Brain Res 181:251-272
27. Grove-Strawser D, Boulware MI, Mermelstein PG (2010) Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience 170:1045-1055
28. Hoshaw BA, Hill TI, Crowley JJ, Malberg JE, Khawaja X, Rosenzweig-Lipson S, Schechter LE, Lucki I (2008) Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission. Eur J Pharmacol 594:109-116
29. Ivanova T, Karolczak M, Beyer C (2001) Estrogen stimulates the mitogen-Activated protein kinase pathway in midbrain astroglia. Brain Res 889:264-269
30. Jover-Mengual T, Zukin RS, Etgen AM (2007) MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 148:1131-1143
31. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C (2000) Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275:18447-18453
32. Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R, Malafosse A (2007) Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61:240-245
33. Khawaja X, Xu J, Liang JJ, Barrett JE (2004) Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res 75:451-460
34. Kuo J, Hamid N, Bondar G, Prossnitz ER, Micevych P (2010) Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes. J Neurosci 30:12950-12957
35. Kuroki Y, Fukushima K, Kanda Y, Mizuno K, Watanabe Y (2001) Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur J Neurosci 13:472-476
36. Lebesgue D, Chevaleyre V, Zukin RS, Etgen AM (2009) Estradiol rescues neurons from global ischemia-induced cell death: Multiple cellular pathways of neuroprotection. Steroids 74:555-561
37. Levin ER (1999) Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 10:374-377
38. Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson S (2007) Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacol 32:2360-2368
39. Marino M, Ascenzi P, Acconcia F (2006) S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids 71:298-303
40. Meitzen J, Mermelstein PG (2011) Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J Chem Neuroanat 4:236-241
41. Mendez P, Azcoitia I, Garcia-Segura LM (2003) Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res 112:170-176
42. Mendez P, Azcoitia I, Garcia-Segura LM (2005) Interdependence of oestrogen and insulin-like growth factor-I in the brain: Potential for analysing neuroprotective mechanisms. J Endocrinol 185:11-17
43. Mercier G, Lennon AM, Renouf B, Dessouroux A, Ramaugé M, Courtin F, Pierre M (2004) MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 24:207-216
44. Micevych PE, Mermelstein PG (2008) Membrane estrogen receptors acting through metabotropic glutamate receptors: An emerging mechanism of estrogen action in brain. Mol Neurobiol 38:66-77
45. Nethrapalli IS, Singh M, Guan X, Guo Q, Lubahn DB, Korach KS, Toran-Allerand CD (2001) Estradiol (E2) elicits SRC phosphorylation in the mouse neocortex: The initial event in E2 activation of the MAPK cascade? Endocrinology 142:5145-5148
46. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. New York, NY: Academic
47. Pietrzkowski Z, Wernicke D, Porcu P, Jameson BA, Baserga R (1992) Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor. Cancer Res 52:6447-6451
48. Polter AM, Li X (2011) Glycogen synthase Kinase-3 is an intermediate modulator of serotonin neurotransmission. Front Mol Neurosci 4:31
49. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57
50. Quesada A, Etgen AM (2002) Functional interactions between estrogen and insulin-like growth factor-I in the regulation of alpha 1B-Adrenoceptors and female reproductive function. J Neurosci 22:2401-2408
51. Quesada A, Micevych PE (2004) Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J Neurosci Res 75:107-116
52. Quesada A, Lee BY, Micevych PE (2008) PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev Neurobiol 68:632-644
53. Ramamoorthy S, Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-736
54. Ramamoorthy S, Melikian HE, Qian Y, Blakely RD (1998) Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins. Methods Enzymol 296:347-370
55. Ramamoorthy S, Shippenberg TS, Jayanthi LD (2011) Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol Ther 129:220-238
56. Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P, Domenici E, Chao MV, Männistö PT, Castrén E (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce Phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacol 32:2152-2162
57. Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW (2008) Rapid estrogen signaling in the brain. Neurosignals 16:140-153
58. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castren E (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23:349-357
59. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S (2005) A role for p38 mitogen-Activated protein kinase in the regulation of the serotonin transporter: Evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25:29-41
60. Sanchez-Margálet V, Goldfine ID, Vlahos CJ, Sung CK (1994) Role of phosphatidylinositol-3-kinase in insulin receptor signaling: Studies with inhibitor, LY294002. Biochem Biophys Res Commun 204:446-452
61. Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, Francesconi W (2002) Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-Term potentiation in the hippocampal CA1 region. J Neurosci 22:3359-3365
62. Scharfman HE, Maclusky NJ (2005) Similarities between actions of estrogen and BDNF in the hippocampus: Coincidence or clue? Trends Neurosci 2:79-85
63. Scharfman HE, MacLusky NJ (2006) Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: Complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 27:415-435
64. Schmidt HD, Duman RS (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18:391-418
65. Selvamani A, Sohrabji F (2010) The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J Neurosci 30:6852-6861
66. Sétáló G Jr., Singh M, Guan X, Toran-Allerand CD (2002) Estradiol-induced phosphorylation of ERK1/2 in explants of the mouse cerebral cortex: The roles of heat shock protein 90 (Hsp90) and MEK2. J Neurobiol 50:1-12
67. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
68. Singh M, Sétáló G Jr., Guan X, Frail DE, Toran-Allerand CD (2000) Estrogen-induced activation of the mitogen-Activated protein kinase cascade in the cerebral cortex of estrogen receptor-Alpha knock-out mice. J Neurosci 20:1694-1700
69. Spencer-Segal JL, Tsuda MC, Mattei L, Waters EM, Romeo RD, Milner TA, McEwen BS, Ogawa S (2012) Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation. Neuroscience 202:131-146
70. Steiner JA, Carneiro AM, Blakely RD (2008) Going with the flow: Trafficking-dependent and-independent regulation of serotonin transport. Traffic 9:1393-1402
71. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT (1994) A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. Cell 77:83-93
72. Sui L, Wang J, Li BM (2008) Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-Term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn Mem 15:762-776
73. Tanis KQ, Duman RS (2007) Intracellular signaling pathways pave roads to recovery for mood disorders. Ann Med 39:531-544
74. Toran-Allerand CD, Singh M, Sétáló G Jr (1999) Novel mechanisms of estrogen action in the brain: New players in an old story. Front Neuroendocrinol. 20:97-121
75. Wade CB, Dorsa DM (2003) Estrogen activation of cyclic adenosine 5'-monophosphate response element-mediated transcription requires the extracellularly regulated kinase/ mitogen-Activated protein kinase pathway. Endocrinology 144:832-838
76. Wilson ME, Liu Y, Wise PM (2002) Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Brain Res Mol Brain Res 102:48-54
77. Yu X, Rajala RV, McGinnis JF, Li F, Anderson RE, Yan X, Li S, Elias RV, Knapp RR, Zhou X, Cao W (2004) Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 beta-estradiol-mediated neuroprotection. J Biol Chem 279:13086-13094
78. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280:15649-15658